Patents currently prevent the manufacturing of any generic versions of Xarelto (rivaroxaban) at this time. The first patent is scheduled to expire in December 2020, which is the earliest date that generic versions could become available. However, lawsuits or other patents for new uses of the drug may delay the manufacturing of a generic Xarelto.
Can I Buy Generic Xarelto?Xarelto® (rivaroxaban) is a prescription medication used to prevent blood clots after hip replacement or knee replacement surgery. It also prevents blood clots and strokes in people with an irregular heart rhythm known as atrial fibrillation. Most recently, it was also approved for the treatment of blood clots (as well as to prevent such clots from recurring). It belongs to a class of drugs known as Factor Xa inhibitors. It is taken once daily by mouth.
Xarelto is manufactured by Janssen Pharmaceuticals, Inc. It is currently under the protection of at least one patent that prevents any generic versions from being manufactured in the United States. Yet, if you search the Internet for "generic Xarelto," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous.
Generic Xarelto may be available from another country, but there is really no way of knowing if you are getting the right medication. You should not buy any generic versions of this drug until there is an approved version available.
When Will a Generic Version Be Available?The first patent is set to expire in December 2020. This is the earliest predictable date that a generic version could become available. However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Xarelto uses. Once the patents expire, there may be several companies that manufacture a generic Xarelto drug.